When evaluating where to buy Selank for laboratory research, investigators require high-purity, lot-tested research compounds backed by comprehensive analytical documentation. Selank is a synthetic heptapeptide derived from the endogenous immunomodulatory peptide tuftsin, extensively evaluated in preclinical literature for its interactions with GABAergic and monoaminergic signaling networks. PX1 Research provides research-grade Selank engineered for in vitro assays and preclinical animal models, complete with third-party HPLC and mass spectrometry verification, endotoxin testing, and same-day dispatch from our US distribution centers.
When evaluating where to buy Selank for laboratory research, investigators require high-purity, lot-tested research compounds backed by comprehensive analytical documentation. Selank is a synthetic heptapeptide derived from the endogenous immunomodulatory peptide tuftsin, extensively evaluated in preclinical literature for its interactions with GABAergic and monoaminergic signaling networks. PX1 Research provides research-grade Selank engineered for in vitro assays and preclinical animal models, complete with third-party HPLC and mass spectrometry verification, endotoxin testing, and same-day dispatch from our US distribution centers.
Selank is a synthetic heptapeptide with the primary amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (Thr-Lys-Pro-Arg-Pro-Gly-Pro). It was engineered by structural modification of the naturally occurring tetrapeptide tuftsin (Thr-Lys-Pro-Arg), an endogenous immunomodulatory fragment of human immunoglobulin G (IgG) heavy chains. By appending a tripeptide C-terminal sequence (Pro-Gly-Pro), molecular pharmacologists successfully stabilized the core peptide against metabolic degradation by circulating aminopeptidases and carboxypeptidases.
In cell-free and tissue homogenate assays, this Pro-Gly-Pro elongation significantly extends the biological half-life of the molecule compared to native tuftsin. The resulting chemical structure possesses a molecular weight of approximately 751.9 g/mol and exhibits favorable solubility in aqueous laboratory vehicles. Researchers seeking to buy Selank for experimental protocols utilize the compound to investigate peptide-receptor interactions, enzymatic inhibition cascades, and central nervous system signaling pathways in controlled research environments.
Preclinical literature reveals that Selank exerts its biological activity through several distinct molecular mechanisms. In rodent brain tissue preparations, autoradiography and radioligand binding studies demonstrate that Selank acts as an allosteric modulator of the gamma-aminobutyric acid type A (GABA-A) receptor complex. Unlike conventional benzodiazepines, Selank does not bind directly to the classical benzodiazepine recognition site; instead, in vitro data indicate it modulates GABA-A receptor subunit affinity, thereby altering chloride channel conductance in response to endogenous GABA.
Additionally, preclinical rodent models indicate that Selank influences monoamine metabolism. High-performance liquid chromatography (HPLC) analyses of brain tissue homogenates show alterations in serotonin (5-HT) and dopamine turnover rates within the hippocampus and hypothalamus following peptide administration. Beyond neurotransmitter dynamics, transcriptomic analyses in neuronal cell cultures demonstrate that Selank upregulates mRNA expression for Brain-Derived Neurotrophic Factor (BDNF) and its primary tyrosine kinase receptor, TrkB. Furthermore, in vitro biochemical assays confirm that Selank inhibits enkephalin-degrading enzymes, such as neutral endopeptidase (neprilysin) and aminopeptidase N, preserving endogenous opioid peptide stability in extracellular matrices.
When designing comparative neurological assays, laboratory investigators frequently contrast Selank with other synthetic regulatory peptides. While Selank primarily modulates GABAergic signaling, enkephalinase activity, and BDNF transcription, Semax—an ACTH(4-10) analog—operates predominantly via melanocortin receptor activation, neurotrophin expression, and cholinergic pathway enhancement. Both compounds represent distinct chemical strategies for modulating central signaling pathways, making them valuable comparative tools in dual-peptide experimental setups.
For studies requiring enhanced enzymatic resistance or specialized tissue permeability, researchers also evaluate N-Acetyl Selank Amidate. This chemical variant incorporates N-terminal acetylation and C-terminal amidation, structural modifications designed to protect the terminal residues from exopeptidase cleavage in complex biological matrices. Comparing native Selank with modified derivatives and broader tuftsin analogs allows laboratories to map structure-activity relationships (SAR) across various cell lines and isolated neuronal preparations. To explore our complete inventory of regulatory sequences, visit our all peptides catalog.
In experimental biology, the validity of scientific data depends entirely on the purity and chemical consistency of the test reagents. Low-purity peptides contaminated with deletion sequences, TFA salts, synthesis reagents, or bacterial toxins introduce unquantifiable noise into experimental models, frequently yielding false-positive or irreproducible results. When purchasing Selank for laboratory investigation, research teams must demand complete transparency regarding synthesis methodologies, analytical verification, and manufacturing standards.
PX1 Research synthesizes research compounds using advanced Solid-Phase Peptide Synthesis (SPPS) protocols. Following synthesis, crude peptides undergo multi-step purification via preparative reverse-phase chromatography. This meticulous processing removes incomplete sequences and residual chemical reagents, yielding a final product that consistently exceeds 99.0% chromatographic purity. Laboratories conducting precise biochemical assays can explore our scientific documentation in the PX1 research library.
To ensure uncompromising quality, every single production lot of Selank supplied by PX1 Research undergoes rigorous independent verification at an ISO 17025-accredited analytical laboratory. Quality assurance relies on two foundational chemical testing methods: Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Electrospray Ionization Mass Spectrometry (ESI-MS).
RP-HPLC establishes chemical purity by separating the primary target peptide from minor related impurities based on hydrophobic interaction. The resulting UV chromatogram demonstrates a sharp, isolated peak corresponding to Selank, confirming a purity profile above 99.0%. Simultaneously, ESI-MS provides exact molecular weight verification, matching the experimental mass-to-charge ratio (m/z) against the theoretical monoisotopic mass of C33H57N11O9. Furthermore, because bacterial lipopolysaccharides (LAL endotoxins) can alter cell culture viability and provoke nonspecific inflammatory cascades in preclinical animal models, PX1 Research quantifies endotoxin levels via chromogenic LAL testing, enforcing a strict maximum threshold of <0.05 EU/mg.
Selank is supplied as a sterile, lyophilized (freeze-dried) powder sealed under inert gas in borosilicate glass vials. Lyophilization preserves chemical stability during transit and storage, but proper reconstitution protocols are essential prior to performing in vitro or ex vivo experiments. All liquid handling procedures must be conducted within a certified laminar flow cabinet utilizing strict aseptic techniques.
To reconstitute lyophilized Selank, investigators typically utilize sterile 0.9% Sodium Chloride (normal saline) or Bacteriostatic Water (containing 0.9% benzyl alcohol as a preservative). The liquid vehicle should be introduced slowly down the interior glass wall of the vial using a precision pipettor or syringe, avoiding direct high-pressure impact onto the peptide cake. The vial should be gently swirled or inverted until complete dissolution is observed. Rapid vortexing or violent agitation must be avoided, as mechanical shear stress can disrupt delicate peptide secondary structures and induce aggregation.
Proper temperature control is critical to prevent peptide hydrolysis, oxidation, and trifluoroacetate (TFA) salt interaction over extended storage periods. Upon receipt at the research facility, unopened vials of lyophilized Selank should be transferred immediately to a climate-controlled freezer maintained at -20°C for short-to-medium term studies, or -80°C for long-term repository storage. Under these desiccated, sub-zero conditions, the lyophilized peptide retains chemical integrity for up to 24 months.
Once reconstituted into an aqueous solution, the peptide becomes significantly more susceptible to degradation pathways. Reconstituted Selank stock solutions should be stored at 2°C to 8°C and utilized within 30 days if formulated with a bacteriostatic agent. If formulated in sterile non-preserved water, solutions should be used immediately or aliquoted into single-use microcentrifuge tubes and frozen at -80°C. Repeated freeze-thaw cycles must be strictly avoided, as phase transitions accelerate physical aggregation and cleavage of peptide bonds.
PX1 Research operates exclusively within a US-manufactured framework, sourcing and synthesizing research peptides in state-of-the-art facilities compliant with current Good Manufacturing Practices (cGMP) and ISO standards. This domestic manufacturing chain eliminates the supply chain disruptions, quality degradation, and regulatory uncertainties associated with unverified overseas distributors.
Every vial of Selank features full lot traceability. Research institutions can cross-reference the batch number printed on the vial directly with our public repository of lot-specific Certificates of Analysis (COAs). These documents provide full RP-HPLC chromatograms, mass spectrum outputs, and quantitative endotoxin test results, ensuring that research teams can validate reagent quality prior to introducing compounds into costly experimental protocols. Principal investigators managing high-throughput laboratories or institution-wide procurement can establish dedicated accounts through our wholesale ordering portal.
Laboratory workflows require dependable fulfillment and rapid order turnaround. PX1 Research maintains centralized distribution infrastructure operating out of California and Arizona. Orders placed before our daily cutoff time are processed and dispatched the same day, Monday through Friday, ensuring minimal transit time to research facilities nationwide.
Peptides are packed in thermal-insulated protective packaging designed to cushion vials against mechanical shock and isolate them from extreme environmental temperatures during transit. Upon arrival, vials should be inspected and immediately transferred to cold storage according to laboratory SOPs. By combining top-tier manufacturing standards, transparent third-party analytical verification, and rapid fulfillment, PX1 Research remains the preferred choice for institutions seeking to buy Selank for rigorous preclinical research.
Where can I buy Selank for laboratory research?
You can buy Selank directly from PX1 Research at our product page (https://px1research.com/product/buy-selank). PX1 Research supplies high-purity, USA-manufactured Selank specifically dedicated to in vitro and preclinical research applications, complete with lot-specific COAs.
What is Selank and what is its chemical structure?
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It is an elongated derivative of the endogenous immunomodulatory tetrapeptide tuftsin, designed with a C-terminal Pro-Gly-Pro sequence to enhance resistance against enzymatic degradation.
What purity level is guaranteed when I buy Selank from PX1 Research?
PX1 Research guarantees that every lot of Selank achieves a minimum chromatographic purity of >99.0% as verified by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC).
How does PX1 Research verify the identity and purity of Selank?
Every batch undergoes independent third-party testing at an ISO 17025-accredited laboratory. Testing includes RP-HPLC for purity profiling, Electrospray Ionization Mass Spectrometry (ESI-MS) for molecular weight confirmation, and chromogenic LAL assays for endotoxin quantification.
What is the key difference between Selank and Semax in preclinical research?
While both are synthetic regulatory peptides developed for central nervous system research, Selank is a tuftsin analog that predominantly influences GABAergic allosteric modulation and enkephalinase inhibition. Semax is an ACTH(4-10) analog that primarily modulates melanocortin pathways and neurotrophin (BDNF/NGF) upregulation.
What is the endotoxin limit for Selank supplied by PX1 Research?
PX1 Research enforces a strict endotoxin threshold of less than 0.05 EU/mg for Selank, preventing lipopolysaccharide contamination from interfering with sensitive cell culture or animal assays.
How should lyophilized Selank be stored upon delivery?
Unopened, lyophilized Selank should be stored at -20°C for short-to-medium term storage, or at -80°C for long-term stability. The dry peptide cake should be kept protected from light and moisture.
How should Selank be reconstituted for in vitro assays?
In a sterile laminar flow hood, introduce sterile 0.9% Sodium Chloride or Bacteriostatic Water slowly down the glass wall of the vial. Gently invert or swirl the vial until the peptide completely dissolves. Avoid violent shaking or vortexing.
Are PX1 Research compounds intended for human consumption or clinical use?
No. All products supplied by PX1 Research, including Selank, are strictly intended for laboratory research use only (in vitro and preclinical animal models). They are not for human consumption, therapeutic, clinical, or diagnostic use.
What are PX1 Research's shipping procedures for Selank orders?
PX1 Research provides same-day shipping for orders placed Monday through Friday before the daily cutoff time. Shipments dispatch from our dual fulfillment centers in California and Arizona using protective thermal packaging.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.